<DOC>
	<DOCNO>NCT00272207</DOCNO>
	<brief_summary>The purpose study determine whether drug Nabilone significantly reduce pain improves quality life patient fibromyalgia .</brief_summary>
	<brief_title>A Trial Assessing Effect Nabilone Pain Quality Life Patients With Fibromyalgia</brief_title>
	<detailed_description>Fibromyalgia disease unknown cause . People fibromyalgia experience diffuse body pain , fatigue , sleep disturbance , generalize stiffness swollen feeling . Fibromyalgia affect 2-6 % general population , affect female commonly male . Symptoms usually start 20 55 year age . No medical treatment specifically approve management fibromyalgia , however , strong evidence antidepressant , exercise , patient education effective reduce pain experience fibromyalgia patient . A recent study four patient suggest possible benefit Nabilone , synthetic cannabinoid , treatment fibromyalgia , however study need . Marijuana common name cannabis . Nabilone ( brand name , CESAMETÂ® ) , synthetic cannabinoid ( form cannabis ) . Cannabinoid receptor exist naturally human body respond naturally occur cannabinoids produce body , well marijuana synthetic cannabinoids like Nabilone . In Canada , Nabilone approve treatment management severe nausea vomit associate cancer chemotherapy may prescribe physician . Research show activate cannabinoid receptor also effect reduce acute chronic pain . Our hypothesis synthetic cannabinoid Nabilone significantly reduce pain experienced patient fibromyalgia improve quality life , compare placebo control group . This evident finding significant difference Visual Analogue Scale pain score , number tender point , average pain threshold , score Fibromyalgia Impact Questionaire .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Nabilone</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>The patient meet The American College Rheumatology ( 1990 ) criterion classification fibromyalgia . [ 5 ] 1870 year old . Any gender . The patient receive benefit tricyclic antidepressant , muscle relaxant , acetaminophen nonsteroidal antiinflammatories management pain . No previous use oral cannabinoids pain management . The patient 's pain well explain diagnosis fibromyalgia . Abnormalities routine baseline blood work include electrolyte , urea creatinine , complete blood count , liver function test ( AST ALT GGT , Alk Phos , LDH ) . Normal test take within 3 month prior study accepted history acute illness since time blood drawn . Heart disease . ( Cannabinoids reduce heart rate blood pressure ) Patients heart disease exclude base history angina , MI CHF well clinical exam . Schizophrenia Psychotic disorder Severe liver dysfunction . ( Patients exclude elevation baseline liver enzyme ) History untreated nonpsychotic emotional disorder . Cognitive impairment . Major illness another body area . Pregnancy . Nursing mother . Patients le 18 year old . History drug dependency . A known sensitivity marijuana cannabinoid agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Fibromyalgia</keyword>
	<keyword>Cannabinoids</keyword>
	<keyword>Nabilone</keyword>
	<keyword>Cesamet</keyword>
	<keyword>Pain</keyword>
</DOC>